Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
remdesivir
Remdesivir could reduce COVID mortality if given early : Study
Researchers from Tokyo Medical and Dental University (TMDU) have found that treatment with remdesivir within nine days of COVID-19…
China Junshi’s potential COVID drug shows promise in small trial
The drug, called VV116, is a derivative of Gilead Sciences's COVID drug Remdesivir and was approved for use in moderate-to-severe…
WHO recommends Pfizer’s Paxlovid for wide geographical distribution
Pfizer’s oral antiviral drug (a combination of Nirmatrelvir and Ritonavir tablets) is strongly recommended for patients with…
FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant
The FDA’s move comes as a blow to the companies which have seen high demand for Sotrovimab after it became one of the few COVID-19…
Parliamentary panel for framing price control regime for COVID medicines medical devices
The panel also recommended exemption of basic customs duty and GST on medicines and medical devices for fighting COVID-19
WHO identifies falsified DESREM remdesivir injection
The genuine manufacturer of DESREM, Mylan Laboratories, has confirmed that the products identified are falsified
Arthritis drug shown to reduce risk of COVID death in large UK trial
More than 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the…
COVID treatment: Centre issues revised guidelines on use of drugs and therapies
The revised guidelines continue to recommend Emergency Use Authorisation (EUA) or off-label use of Remdesivir in patients with…
Emmes completes third ACTT clinical trial for COVID
The ACTT-III trial assessed the efficacy and safety of interferon beta-1a plus Remdesivir compared to Remdesivir alone in…